Table: Oncolys Biopharma - 9-MTH parent results

Oncolys Biopharma

06/11/2020 06:00

Nov 6 (Reuters)- 
             Oncolys Biopharma Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Sep 30, 2020        Sep 30, 2019     Dec 31, 2020 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            207 mln             640 mln                    
                 (-67.5 pct)        (+440.5 pct)                  
  Operating       loss 1.17         loss 586 mln                  
  Recurring       loss 1.19         loss 587 mln                  
  Net             loss 1.55         loss 590 mln                  
  EPS          loss 107.64 yen     loss 42.73 yen                 
  Ann Div                                NIL              NIL     
  -Q2 div            NIL                 NIL                      
  -Q4 div                                NIL              NIL     
  
  NOTE - Oncolys Biopharma Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4588.T